Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Phase 1/2 Active not recruiting 15 enrolled Regenerative Ocular Immunobiologics LLC

RandomizedParallel-groupTriple-blindTreatment

Summary

A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of d-MAPPS™ Ophthalmic Solution in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGHVD)

Timeline

Start: 2025-01-10
Primary completion: 2026-12
Completion: 2026-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	d-MAPPS	Unknown	—	Other

Indications

No indication recorded.